HCA Healthcare Appoints John W. Chidsey, III as New Independent Director

HCA Healthcare Appoints John W. Chidsey, III as New Independent Director

NASHVILLE, Tenn.–(BUSINESS WIRE)–HCA Healthcare, Inc. (NYSE: HCA), one of the nation’s leading healthcare providers, today announced that its board of directors has appointed John W. Chidsey, III as an independent director, effective July 15, 2025. With his addition, HCA Healthcare’s board of directors increases from nine to ten members.

Mr. Chidsey will serve as a member of HCA Healthcare’s audit and compliance committee, compensation committee and patient safety and quality of care committee.

Mr. Chidsey most recently served as the global chief executive officer of Subway. He previously served as chief executive officer of Burger King Holdings, Inc. and held significant leadership roles at Cendant Corporation. Earlier in his career, he also held various senior financial leadership roles at PepsiCo.

Mr. Chidsey also currently serves on the board of Norwegian Cruise Line Holdings Ltd. and previously served on the boards of Encompass Health Corporation, Burger King Holdings, Inc. (as chairman) and Brinker International, Inc.

“John Chidsey’s distinguished career demonstrates his extensive experience in leading corporate strategy at large, complex public and private companies, and we are confident he will provide invaluable insight as a board member,” said Thomas F. Frist III, chairman of the board of HCA Healthcare. “John’s financial, operational and executive leadership experience and expertise will complement HCA Healthcare’s commitment to the care and improvement of human life. We are pleased to announce his addition to our board.”

Mr. Chidsey holds a B.A. degree from Davidson College, as well as MBA and J.D. degrees from Emory University.

About HCA Healthcare

Nashville-based HCA Healthcare is one of the nation’s leading providers of healthcare services comprising 192 hospitals and approximately 2,500 ambulatory sites of care, including surgery centers, freestanding ERs, urgent care centers, and physician clinics, in 20 states and the United Kingdom. With its founding in 1968, HCA Healthcare created a new model for hospital care in the United States, using combined resources to strengthen hospitals, deliver patient-focused care and improve the practice of medicine. HCA Healthcare has conducted a number of clinical studies, including one that demonstrated that full-term delivery is healthier than early elective delivery of babies and another that identified a clinical protocol that can reduce bloodstream infections in ICU patients by 44%. HCA Healthcare is a learning health system that uses its approximately 44 million annual patient encounters to advance science, improve patient care and save lives.

All references to “Company,” “HCA” and “HCA Healthcare” as used throughout this document refer to HCA Healthcare, Inc., and its affiliates.

INVESTOR CONTACT:

Frank Morgan

615-344-2688

MEDIA CONTACT:

Harlow Sumerford

615-344-1851

KEYWORDS: United States North America Tennessee

INDUSTRY KEYWORDS: Managed Care Hospitals Health

MEDIA:

Logo
Logo

Fidelis Insurance Group Schedules Second Quarter 2025 Financial Results Conference Call

Fidelis Insurance Group Schedules Second Quarter 2025 Financial Results Conference Call

PEMBROKE, Bermuda–(BUSINESS WIRE)–
Fidelis Insurance Holdings Limited (NYSE:FIHL) (“Fidelis Insurance Group” or the “Company”), a global specialty insurer, announced today that it expects to release financial results for the second quarter ended June 30, 2025, on August 13, 2025, after the close of the financial markets. These documents will be available via the Investors section of the Company’s website at https://investors.fidelisinsurance.com.

Dan Burrows, Group Chief Executive Officer, Allan Decleir, Group Chief Financial Officer, and Jonny Strickle, Group Managing Director, will host an investor teleconference, including a question-and-answer period, on August 14, 2025, at 9:00 a.m. ET to discuss the second quarter results as well as related matters.

The teleconference can be accessed by dialing 1-404-975-4839 (U.S. callers), or 1-833-470-1428 (international callers), and entering the passcode 118994 approximately 10 minutes in advance of the call. A live, listen-only webcast of the call will also be available via the Investors section of the Company’s website at https://investors.fidelisinsurance.com.

About Fidelis Insurance Group

Fidelis Insurance Group is a global specialty insurer, leveraging strategic partnerships to offer innovative and tailored insurance solutions.

We have a highly diversified portfolio that we believe allows us to take advantage of the opportunities presented by evolving (re)insurance markets, proactively shift our business mix across market cycles, and produce superior underwriting returns.

Headquartered in Bermuda, with offices in Ireland and the United Kingdom, Fidelis Insurance Group operating companies have an insurer financial strength rating of A from AM Best, A- from S&P and A3 from Moody’s. For additional information about Fidelis Insurance Group, our people, and our products please visit our website at www.FidelisInsurance.com.

CAUTIONARY STATEMENT CONCERNING FORWARD-LOOKING STATEMENTS

Certain statements contained in this press release, in interviews and in related posts, constitute “forward-looking statements,” and are made pursuant to the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Management has based these forward-looking statements on its current expectations, assumptions, estimates and projections. While they believe these expectations, assumptions, estimates and projections are reasonable, such forward-looking statements are only predictions and are subject to known and unknown risks and uncertainties, many of which are beyond management’s control. These statements involve risks and uncertainties that may cause Fidelis’ actual results, performance or achievements to differ materially from any future results, performance or achievements expressed or implied by these forward-looking statements. Forward-looking statements speak only as of the date they are made. Readers are cautioned not to rely on forward-looking statements, and, except as required by law, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, Fidelis assumes no obligation and does not intend to update or revise these forward-looking statements after the date of this press release, whether as a result of new information, future events, or otherwise.

Fidelis Insurance Group Investor Contact:

Fidelis Insurance Group

Miranda Hunter

+1 441 279 2561

[email protected]

Fidelis Insurance Group Media Contact:

Rein4ce

Sarah Hills

+44 (0)7718 882011

[email protected]

KEYWORDS: Caribbean United States Bermuda North America

INDUSTRY KEYWORDS: Professional Services Insurance Finance

MEDIA:

Dynex Capital, Inc. Declares Monthly Common Stock Dividend of $0.17 Per Common Share for July 2025

Dynex Capital, Inc. Declares Monthly Common Stock Dividend of $0.17 Per Common Share for July 2025

GLEN ALLEN, Va.–(BUSINESS WIRE)–
Dynex Capital, Inc. announced today the Company’s Board of Directors has declared a cash dividend of $0.17 per share on its Common Stock (NYSE: DX) for July 2025. The dividend is payable on August 1, 2025, to shareholders of record as of July 23, 2025.

About Dynex Capital

Dynex Capital, Inc. is a financial services company committed to ethical stewardship of stakeholders’ capital; employing comprehensive risk management and disciplined capital allocation to generate dividend income and long-term total returns through the diversified financing of real estate assets in the United States. Dynex operates as a REIT and is internally managed to maximize stakeholder alignment. Additional information about Dynex Capital, Inc. is available at www.dynexcapital.com.

Forward Looking Statement

“Safe Harbor” Statement under the Private Securities Litigation Reform Act of 1995: Statements in this press release regarding the business of Dynex Capital, Inc. that are not historical facts are “forward-looking statements” that involve risks and uncertainties. For a discussion of these risks and uncertainties, which could cause actual results to differ from those contained in the forward-looking statements, see “Risk Factors” in the Company’s Annual Report on Form 10-K and other reports filed with the Securities and Exchange Commission.

Alison Griffin

804-217-5897

KEYWORDS: United States North America Virginia

INDUSTRY KEYWORDS: Professional Services Other Professional Services Finance Asset Management Consulting Personal Finance

MEDIA:

Logo
Logo

TARIFF PAUSE SPURS GLOBAL MANUFACTURING ACTIVITY IN JUNE, WITH GLOBAL SUPPLY CHAINS NOW OPERATING CLOSE TO FULL CAPACITY: GEP GLOBAL SUPPLY CHAIN VOLATILITY INDEX

PR Newswire


  • Europe exits two-year slump, led by German export rebound and domestic demand recovery
  • U.S. manufacturers purchasing surges ahead of U.S. ‘tariff pause’ ending

  • Asia supply chains pick up, though capacity remains underutilized in Southeast Asia
  • No signs of cost inflation escalation yet despite the 10% universal tariff imposed by the U.S.


CLARK, N.J.
, July 11, 2025 /PRNewswire/ — GEP Global Supply Chain Volatility Index — a leading indicator tracking demand conditions, shortages, transportation costs, inventories, and backlogs based on a monthly survey of 27,000 businesses — jumped to -0.17 in June, from -0.46 in May, its highest in 2025 as worldwide supply chain activity picked up despite the 10% tariffs imposed by the US administration.

For the first time in more than two years, European manufacturers operated at full tilt, driven by front-loaded orders from US customers, and a rebound in both domestic and export demand, particularly across Germany.

In North America, demand for inputs surged as U.S. manufacturers moved quickly to secure inputs – commodities, parts, components and raw materials – ahead of a potential end to the current tariff pause.


Asia’s supply chains also showed signs of recovery
, with stronger activity in India, Japan, and South Korea. However, spare capacity remains across Southeast Asia, where factory purchasing continues to lag, notably in China.

Notably, there is no evidence in the data of cost inflation escalating dramatically, despite the tariffs.

“In June, Europe shook off its long slump and global supply chains ran at full capacity — despite the uncertainty and on-and-off again tariffs,” said John Piatek, VP, Consulting, GEP. “But under the surface, companies are putting in place contingencies: stockpiling inputs, reshaping supplier networks, near-shoring operations, and securing supply chain financing.”

Interpreting the data:

Index > 0, supply chain capacity is being stretched. The further above 0, the more stretched supply chains are.

Index < 0, supply chain capacity is being
underutilized.
The further below 0, the more
underutilized
supply chains are.

Interpreting the data:

Index > 0, supply chain capacity is being stretched. The further above 0, the more stretched supply chains are.

Index < 0, supply chain capacity is being underutilized. The further below 0, the more underutilized supply chains are.


JUNE 2025 REGIONAL KEY FINDINGS


  • ASIA:

    Index rises to -0.27, from -0.40, indicating a pick-up in Asian market activity, but the region’s supply chains remain underutilized overall. This mostly reflects subdued factory conditions in Southeast Asia.

  • NORTH AMERICA:

    Index rises to -0.06, from -0.24 as US manufacturers ramp up purchasing sharply ahead of the tariff pause coming to an end. North American supply chains effectively ran at full capacity in June.

  • EUROPE:

    Index rises to 0.01, from -0.30, signaling full capacity utilization across Europe’s supply chains in June as the continent’s industrial sector emerges from its prolonged downturn.
  • U.K.:
    Index rises to -0.41, from -0.97, its highest for seven months, but still indicative of an elevated level of slack across the U.K.’s supply chains.


JUNE 2025 KEY FINDINGS 

  • DEMAND: Global factory purchasing activity continued to trend upwards in June, with demand at its most robust in just over a year. This was driven by a considerable rise in North America, driven by the US, as manufacturers ramped up buying ahead of the pause on US tariffs coming to an end.
  • INVENTORIES: There were increased reports from businesses of a rise in stockpiling due to price or supply concerns during June. Mentions of safety buffers being built into warehouses were their highest so far in 2025 globally, with the prospect of higher tariffs driving procurement managers into precautionary action.
  • MATERIAL SHORTAGES: The global item shortages indicator, which measures the prevalence of supply problems, remains historically low, indicating robust availability.
  • LABOR SHORTAGES: Suppliers’ workforce capacity remains sufficient to process current order loads, according to our data. Reports of manufacturing backlogs rising due to staff shortages remain stable at historically typical levels.
  • TRANSPORTATION: Global transportation costs were once again in line with their long-term average in June. Reports from surveyed businesses of logistic cost pressures remain anchored.

For more information, visit www.gep.com/volatility.
Note: Full historical data dating back to January 2005 is available for subscription. Please contact [email protected].
The next release of the GEP Global Supply Chain Volatility Index will be 8 a.m. ET, Aug. 12, 2025.

About the GEP Global Supply Chain Volatility Index

The GEP Global Supply Chain Volatility Index is produced by S&P Global and GEP. It is derived from S&P Global’s PMI® surveys, sent to companies in over 40 countries, totaling around 27,000 companies. The headline figure is a weighted sum of six sub-indices derived from PMI data, PMI Comments Trackers and PMI Commodity Price & Supply Indicators compiled by S&P Global. For more information about the methodology, click here.

About GEP

GEP® delivers AI-powered procurement and supply chain solutions that help global enterprises become more agile and resilient, operate more efficiently and effectively, gain competitive advantage, boost profitability and increase shareholder value. Headquartered in Clark, New Jersey, GEP has offices and operations centers across Europe, Asia, Africa and the Americas. To learn more, visit www.gep.com.

About S&P Global

S&P Global (NYSE: SPGI) S&P Global provides essential intelligence. We enable governments, businesses and individuals with the right data, expertise and connected technology so that they can make decisions with conviction. From helping our customers assess new investments to guiding them through ESG and energy transition across supply chains, we unlock new opportunities, solve challenges and accelerate progress for the world. We are widely sought after by many of the world’s leading organizations to provide credit ratings, benchmarks, analytics and workflow solutions in the global capital, commodity and automotive markets. With every one of our offerings, we help the world’s leading organizations plan for tomorrow, today.


Media Contacts

Derek Creevey

Joe Hayes

S&P Global Market Intelligence

Director, Public Relations                 

Principal Economist

Corporate Communications

GEP

S&P Global Market Intelligence               

Email: [email protected]

Phone: +1 646-276-4579

Phone: +44-1344-328-099

Email:

Email:


[email protected]


[email protected]

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/tariff-pause-spurs-global-manufacturing-activity-in-june-with-global-supply-chains-now-operating-close-to-full-capacity-gep-global-supply-chain-volatility-index-302502860.html

SOURCE GEP

MicroCloud Hologram Inc. Announces It Has Purchased Up to $200 Million in Bitcoin and Cryptocurrency-Related Securities Derivatives, with a Current Cumulative Investment Income of $34.02 Million

SHENZHEN, China, July 11, 2025 (GLOBE NEWSWIRE) — MicroCloud Hologram Inc. (NASDAQ: HOLO), (“HOLO” or the “Company”), a technology service provider, they announced that they have purchased up to $200 million in Bitcoin and cryptocurrency-related securities derivatives. As of July 11, the cumulative investment income have reached $34.02 million. HOLO currently holds $394 million in cash reserves. The company plans to allocate these $394 million reserves toward derivatives and technology development in cutting-edge fields such as Bitcoin-related blockchain, quantum computing, quantum holography, and AI-powered AR. This move marks HOLO’s further exploration and practice in the cryptocurrency sector while also demonstrating its determination and strategic vision for future business expansion.

The purchased Bitcoin and its derivatives this time will be incorporated into HOLO’s capital reserve strategy, aiming to enhance the company’s financial stability and long-term growth potential through diversified investments. HOLO stated that purchasing Bitcoin and cryptocurrency derivatives is a key initiative in its exploration of the cryptocurrency market, helping it gain insights into market mechanisms, price fluctuations, and investment strategies. Through this plan, HOLO seeks to accumulate valuable experience for future business expansion and capital operations in the cryptocurrency sector.

The company currently holds approximately $394 million in cash reserves. The allocated funds of up to $200 million will primarily be used to invest in Bitcoin or other cryptocurrencies with significant market influence and growth potential, as well as related securities derivatives. These assets will become a crucial part of HOLO’s financial reserves, helping to enhance the diversity and risk resilience of its overall asset portfolio. Meanwhile, HOLO also announced that its cumulative investment income has now reached $34.02 million. This figure highlights HOLO’s commitment to maintaining a strong financial position while also striving to create long-term value for its shareholders. HOLO emphasized that it will continue to uphold a prudent business strategy, enhance profitability and market competitiveness, and generate greater returns for its shareholders.

About MicroCloud Hologram Inc.

MicroCloud is committed to providing leading holographic technology services to its customers worldwide. MicroCloud’s holographic technology services include high-precision holographic light detection and ranging (“LiDAR”) solutions, based on holographic technology, exclusive holographic LiDAR point cloud algorithms architecture design, breakthrough technical holographic imaging solutions, holographic LiDAR sensor chip design and holographic vehicle intelligent vision technology to service customers that provide reliable holographic advanced driver assistance systems (“ADAS”). MicroCloud also provides holographic digital twin technology services for customers and has built a proprietary holographic digital twin technology resource library. MicroCloud’s holographic digital twin technology resource library captures shapes and objects in 3D holographic form by utilizing a combination of MicroCloud’s holographic digital twin software, digital content, spatial data-driven data science, holographic digital cloud algorithm, and holographic 3D capture technology. For more information, please visit http://ir.mcholo.com/

Safe Harbor Statement

This press release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. When the Company uses words such as “may,” “will,” “intend,” “should,” “believe,” “expect,” “anticipate,” “project,” “estimate,” or similar expressions that do not relate solely to historical matters, it is making forward-looking statements. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that may cause the actual results to differ materially from the Company’s expectations discussed in the forward-looking statements. These statements are subject to uncertainties and risks including, but not limited to, the following: the Company’s goals and strategies; the Company’s future business development; product and service demand and acceptance; changes in technology; economic conditions; reputation and brand; the impact of competition and pricing; government regulations; fluctuations in general economic; financial condition and results of operations; the expected growth of the holographic industry and business conditions in China and the international markets the Company plans to serve and assumptions underlying or related to any of the foregoing and other risks contained in reports filed by the Company with the Securities and Exchange Commission (“SEC”), including the Company’s most recently filed Annual Report on Form 10-K and current report on Form 6-K and its subsequent filings. For these reasons, among others, investors are cautioned not to place undue reliance upon any forward-looking statements in this press release. Additional factors are discussed in the Company’s filings with the SEC, which are available for review at www.sec.gov. The Company undertakes no obligation to publicly revise these forward-looking statements to reflect events or circumstances that arise after the date hereof.

Contacts
MicroCloud Hologram Inc.
Email: [email protected]



Evaxion finalizes agreement with EIB to convert debt into equity

  • Evaxion and the European Investment Bank (EIB) have finalized a debt settlement agreement of €3.5 million out of Evaxion’s €7 million loan with EIB, to be used for EIB to purchase €3.5 million worth of ordinary Evaxion warrants
  • EIB will purchase the warrants at a price of $4.87 corresponding to a premium of 89% to the share price by market close yesterday
  • The agreement immediately increases Evaxion’s equity by $4.1 million (€3.5 million)
  • Further, the agreement also substantially reduces Evaxion’s overall liabilities, simplifies its balance sheet and improves its financial flexibility and cash flow

COPENHAGEN, Denmark, July 11, 2025 – Evaxion A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, has finalized its agreement with the European Investment Bank (EIB) to convert debt into equity.

EIB will convert €3.5 million of its €7 million loan to Evaxion into equity via a purchase of ordinary Evaxion warrants at a price of $4.87, corresponding to a premium of 89% to the share price by market close yesterday. The agreement immediately increases Evaxion’s equity by $4.1 million (€3.5 million), bolstering Evaxion’s capital structure. Further, it substantially reduces Evaxion’s overall liabilities, simplifies its balance sheet and improves its financial flexibility and cash flow.

“We are delighted to finalize the agreement with the EIB on favourable terms for Evaxion and our shareholders. I would like to thank the EIB for their support and very constructive approach in the negotiations. The agreement further simplifies our balance sheet and improves our cash flow, which is an important element in the financial management of the company,” says Thomas F. Schmidt, CFO of Evaxion.

Contact information 
Evaxion A/S
Mads Kronborg
Vice President, Investor Relations & Communication
+45 53 54 82 96
[email protected]

About Evaxion

Evaxion is a pioneering TechBio company based upon its AI platform, AI-Immunology™. Evaxion’s proprietary and scalable AI prediction models harness the power of artificial intelligence to decode the human immune system and develop novel immunotherapies for cancer, bacterial diseases, and viral infections. Based upon AI-Immunology™, Evaxion has developed a clinical-stage oncology pipeline of novel personalized vaccines and a preclinical infectious disease pipeline in bacterial and viral diseases with high unmet medical needs. Evaxion is committed to transforming patients’ lives by providing innovative and targeted treatment options. For more information about Evaxion and its groundbreaking AI-Immunology™ platform and vaccine pipeline, please visit our website.

Forward-looking statement 
This announcement contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The words “target,” “believe,” “expect,” “hope,” “aim,” “intend,” “may,” “might,” “anticipate,” “contemplate,” “continue,” “estimate,” “plan,” “potential,” “predict,” “project,” “will,” “can have,” “likely,” “should,” “would,” “could,” and other words and terms of similar meaning identify forward-looking statements. Actual results may differ materially from those indicated by such forward-looking statements as a result of various factors, including, but not limited to, risks related to: our financial condition and need for additional capital; our development work; cost and success of our product development activities and preclinical and clinical trials; commercializing any approved pharmaceutical product developed using our AI platform technology, including the rate and degree of market acceptance of our product candidates; our dependence on third parties including for conduct of clinical testing and product manufacture; our inability to enter into partnerships; government regulation; protection of our intellectual property rights; employee matters and managing growth; our ADSs and ordinary shares, the impact of international economic, political, legal, compliance, social and business factors, including inflation, and the effects on our business from other significant geopolitical and macro-economic events; and other uncertainties affecting our business operations and financial condition. For a further discussion of these risks, please refer to the risk factors included in our most recent Annual Report on Form 20-F and other filings with the US Securities and Exchange Commission (SEC), which are available at www.sec.gov. We do not assume any obligation to update any forward-looking statements except as required by law. 



TriNet to Report Second Quarter 2025 Financial Results on July 25

PR Newswire


DUBLIN, Calif.
, July 11, 2025 /PRNewswire/ — TriNet (NYSE: TNET), a leading provider of comprehensive human resources solutions for small and medium-size businesses (SMBs), today announced it will release financial results for the second quarter ended June 30, 2025 before U.S. market hours on Friday, July 25, 2025.

TriNet will host a conference call at 5:30 a.m. PT (8:30 a.m. ET) on July 25, 2025, to discuss the financial results. A live webcast of the conference call can be accessed on the Investor Relations section of TriNet’s website at investor.trinet.com. Participants can pre-register for the webcast by going to: https://events.q4inc.com/attendee/650432206.

Participants can also pre-register for the upcoming conference call. Those who pre-register will receive a unique PIN, enabling instant access to the call. To pre-register, visit: https://dpregister.com/sreg/10201467/ff917b6f7a.

Participants who do not pre-register for the call can still join by dialing +1 (412) 317-5426 and asking to attend the TriNet second quarter earnings conference call.

A replay of the webcast will be available on the TriNet site for approximately one year.

About TriNet

TriNet (NYSE: TNET) provides comprehensive HR solutions, technology, expertise, and access to world-class benefits that enable SMBs to attract and develop top-tier talent. Rooted in more than 30 years of supporting entrepreneurs and adapting to the ever-changing modern workplace, TriNet empowers SMBs to focus on what matters most—growing their business and enabling their people. For more information, visit TriNet.com or follow us on Facebook, LinkedIn and Instagram


Investors:


Media:

Alex Bauer

Renee Brotherton/Josh Gross

TriNet

TriNet


[email protected]


[email protected]


[email protected]

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/trinet-to-report-second-quarter-2025-financial-results-on-july-25-302503081.html

SOURCE TriNet Group, Inc.

Uxin to Present at the Emerging Growth Conference on July 17, 2025

PR Newswire


BEIJING
, July 11, 2025 /PRNewswire/ — Uxin Limited (“Uxin” or the “Company”) (Nasdaq: UXIN), China’s leading used car retailer, is pleased to announce that it has been invited to present at the upcoming Emerging Growth Conference.

Date: July 17th, 2025
Time: 9:40 – 10:10 a.m. ET
Registration Link:  https://goto.webcasts.com/starthere.jsp?ei=1717085&tp_key=408af67859&sti=uxin

Uxin cordially invites individual and institutional investors as well as advisors and analysts to attend its real-time, interactive presentation at the Emerging Growth Conference.

Mr. Feng Lin, Chief Financial Officer of Uxin, will give a presentation and subsequently open the floor for questions. Investors, analysts and investment advisors are encouraged to register early for the conference and to submit questions in advance to [email protected] or ask your questions during the event.

If attendees are not able to join the event live on the day of the conference, an archived webcast will also be available on EmergingGrowth.com and on the Emerging Growth YouTube Channel
http://www.YouTube.com/EmergingGrowthConference.

About Uxin
Uxin is China’s leading used car retailer, pioneering industry transformation with advanced production, new retail experiences, and digital empowerment. We offer high-quality and value-for-money vehicles as well as superior after-sales services through a reliable, one-stop, and hassle-free transaction experience. Under our omni-channel strategy, we are able to leverage our pioneering online platform to serve customers nationwide and establish market leadership in selected regions through offline superstores with inventory capacities ranging from 2,000 to 8,000 vehicles. Leveraging our extensive industry data and continuous technology innovation throughout more than ten years of operation, we have established strong used car management and operation capabilities. We are committed to upholding our customer-centric approach and driving the healthy development of China’s used car industry.

About the Emerging Growth Conference
The Emerging Growth Conference is an effective way for public companies to present and communicate their new products, services and other major announcements to the investment community from the convenience of their office, in a time efficient manner.

The Conference focus and coverage includes companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long term growth. Its audience includes potentially tens of thousands of individual and institutional investors, as well as investment advisors and analysts.

All sessions will be conducted through video webcasts and will take place in the Eastern time zone.

Safe Harbor Statement
This press release contains statements that may constitute “forward-looking” statements which are made pursuant to the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as “will,” “expects,” “anticipates,” “aims,” “future,” “intends,” “plans,” “believes,” “estimates,” “likely to,” and similar statements. Statements that are not historical facts, including statements about Uxin’s beliefs, plans, and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. A number of factors could cause actual results to differ materially from those contained in any forward-looking statement, including but not limited to the following: the risk and uncertainties as to the timing of the entry into definitive agreements or consummation of the transactions; the risk that certain closing conditions of the transactions may not be satisfied on a timely basis, or at all; impact of the COVID-19 pandemic; Uxin’s goal and strategies; its expansion plans and successful completion of certain financing transactions; its future business development, financial condition and results of operations; Uxin’s expectations regarding demand for, and market acceptance of, its services; its ability to provide differentiated and superior customer experience, maintain and enhance customer trust in its platform, and assess and mitigate various risks, including credit; its expectations regarding maintaining and expanding its relationships with business partners, including financing partners; trends and competition in China’s used car e-commerce industry; the laws and regulations relating to Uxin’s industry; the general economic and business conditions; and assumptions underlying or related to any of the foregoing.

For investor and media enquiries, please contact:

Uxin Limited Investor Relations
Uxin Limited
Email: [email protected]

The Blueshirt Group
Mr. Jack Wang
Phone: +86 166-0115-0429
Email: [email protected]

Cision View original content:https://www.prnewswire.com/news-releases/uxin-to-present-at-the-emerging-growth-conference-on-july-17-2025-302503117.html

SOURCE Uxin Limited

Gates Industrial Announces Second-Quarter 2025 Earnings Release Date

PR Newswire


DENVER
, July 11, 2025 /PRNewswire/ — Gates Industrial Corporation plc (NYSE:GTES) will issue its second-quarter earnings release before the market opens on Wednesday, July 30, 2025.  Management will host a webcast and conference call on the same day at 11:30 a.m. Eastern time to discuss Gates Industrial’s financial results. The conference call can be accessed as follows:

  • By dialing (888) 414-4601 (domestic) or +1 (646) 960-0313 (international) and requesting the Gates Industrial Corporation Second-Quarter 2025 Earnings Conference Call or providing the Conference ID of 5772067.
  • Live webcast accessed through Gates Industrial’s website at investors.gates.com.

An audio replay of the conference call will be available from approximately 2:30 p.m. Eastern time on July 30, 2025, until 11:59 p.m. Eastern time on August 6, 2025, and can be accessed domestically or internationally by dialing (800) 770-2030 or +1 (647) 362-9199, respectively, and providing the passcode 5772067, or by accessing Gates Industrial’s website at investors.gates.com.

About Gates Industrial Corporation plc

Gates is a global manufacturer of innovative, highly engineered power transmission and fluid power solutions. Gates offers a broad portfolio of products to diverse replacement channel customers, and to OEMs as specified components. Gates participates in many sectors of the industrial and consumer markets. Our products play essential roles in a diverse range of applications across a wide variety of end markets ranging from harsh and hazardous industries to everyday consumer applications including virtually every form of transportation. Our products are sold in more than 130 countries across our four commercial regions: the Americas; Europe, Middle East & Africa; Greater China; and East Asia & India.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/gates-industrial-announces-second-quarter-2025-earnings-release-date-302502948.html

SOURCE Gates Industrial Corporation plc

IM CANNABIS ANNOUNCES FILING OF SHELF REGISTRATION STATEMENT ON FORM F-3

PR Newswire


TORONTO and GLIL YAM, Israel
, July 11, 2025 /PRNewswire/ — IM Cannabis Corp. (“IMC” or the “Company“) (Nasdaq: IMCC), a leading medical cannabis company with operations in Israel and Germany, is pleased to announce the filing and effectiveness of a shelf registration statement (the “Shelf Registration“) on Form F-3 with the Securities and Exchange Commission (“SEC“).

IM Cannabis Logo

The Shelf Registration will allow the Company to offer and sell, from time to time, up to an aggregate of $50 million of its common shares, warrants, units, or a combination thereof (together, the “Securities“), on a registered basis, subject to market conditions, the Company’s capital needs, and limitations imposed by SEC rules and applicable securities laws. The terms of any such offering, including the specific terms and prices of the Securities, will be determined at the time of such offering and be made solely by means of the prospectus included in the Registration Statement and any prospectus supplement that may be filed with the SEC relating to such offering.

The Shelf Registration does not constitute a commitment by the Company to sell any specific amount of Securities. Any further offerings under the Shelf Registration, if made, will be subject to the Company’s discretion and applicable market conditions.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of, the Securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under applicable securities laws.

About IM Cannabis Corp.

IMC (Nasdaq: IMCC) is an international cannabis company that provides premium cannabis products to medical patients in Israel and Germany, two of the largest medical cannabis markets. The Company has focused its resources to achieve sustainable and profitable growth in its highest value markets, Israel and Germany. The Company leverages a transnational ecosystem powered by a unique data-driven approach and a globally sourced product supply chain. With an unwavering commitment to responsible growth and compliance with the strictest regulatory environments, the Company strives to amplify its commercial and brand power to become a global high-quality cannabis player.

The IMC ecosystem operates in Israel through its subsidiaries, which imports and distributes cannabis to medical patients, leveraging years of proprietary data and patient insights. The Company also operates medical cannabis retail pharmacies, online platforms, distribution centers, and logistical hubs in Israel that enable the safe delivery and quality control of IMC products throughout the entire value chain. In Germany, the IMC ecosystem operates through Adjupharm GmbH, where it distributes cannabis to pharmacies for medical cannabis patients.

Disclaimer for Forward-Looking Statements

This press release contains forward-looking information or forward-looking statements under applicable Canadian and United States securities laws (collectively, “forward-looking statements“). All information that addresses activities or developments that we expect to occur in the future are forward-looking statements. Forward-looking statements are often, but not always, identified by the use of words such as “seek”, “anticipate”, “believe”, “plan”, “estimate”, “expect”, “likely” and “intend” and statements that an event or result “may”, “will”, “should”, “could” or “might” occur or be achieved and other similar expressions. Forward-looking statements are based on the estimates and opinions of management on the date the statements are made. In the press release, such forward-looking statements include, but are not limited to, statements relating to the Company’s ability to access the capital markets, raise future financing, or sell Securities pursuant to the Shelf Registration.

The above lists of forward-looking statements and assumptions are not exhaustive. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. Actual results may differ materially from those currently anticipated or implied by such forward-looking statements due to a number of factors and risks. These include: the failure of the Company to comply with applicable regulatory requirements in a highly regulated industry; unexpected changes in governmental policies and regulations in the jurisdictions in which the Company operates; the Company’s ability to continue to meet the listing requirements of the Nasdaq Capital Market; any unexpected failure to maintain in good standing or renew its licenses; the ability of the Company and its subsidiaries (collectively, the “Group“) to deliver on their sales commitments or growth objectives; the reliance of the Group on third-party supply agreements to provide sufficient quantities of medical cannabis to fulfil the Group’s obligations; the Group’s possible exposure to liability, the perceived level of risk related thereto, and the anticipated results of any litigation or other similar disputes or legal proceedings involving the Group; the impact of increasing competition; any lack of merger and acquisition opportunities; adverse market conditions; the inherent uncertainty of production quantities, qualities and cost estimates and the potential for unexpected costs and expenses; risks of product liability and other safety-related liability from the usage of the Group’s cannabis products; supply chain constraints; reliance on key personnel; the risk of defaulting on existing debt; risks surrounding war, conflict and civil unrest in Eastern Europe and the Middle East, including the impact of the multi-front war Israel is facing on the Company, its operations and the medical cannabis industry in Israel; risks associated with the Company focusing on the Israel and Germany markets; the inability of the Company to achieve sustainable profitability and/or increase shareholder value; the inability of the Company to actively manage costs and/or improve margins; the inability of the company to grow and/or maintain sales; the inability of the Company to meet its goals and/or strategic plans; the inability of the Company to reduce costs and/or maintain revenues; the Company’s inability to take advantage of the legalization of medicinal cannabis in Germany; the Company’s inability to access the capital markets, raise future financing, and/or sell Securities pursuant to the Shelf Registration.

Please see the other risks, uncertainties and factors set out under the heading “Risk Factors” in the Company’s annual report dated March 31, 2025, which is available on the Company’s issuer profile on SEDAR+ at www.sedarplus.ca and Edgar at www.sec.gov/edgar. Any forward-looking statement included in this press release is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the date such forward looking information is made. The Company does not undertake any obligation to update forward-looking statements except as required by applicable securities laws. Investors should not place undue reliance on forward-looking statements. Forward-looking statements contained in this press release are expressly qualified by this cautionary statement.

Logo: https://mma.prnewswire.com/media/1742228/IM_Cannabis_Logo.jpg

Company Contact:

Anna Taranko

Director Investor & Public Relations
IM Cannabis Corp.
+49 157 80554338
[email protected] 

Oren Shuster

Chief Executive Officer
IM Cannabis Corp.
[email protected]

Cision View original content:https://www.prnewswire.com/news-releases/im-cannabis-announces-filing-of-shelf-registration-statement-on-form-f-3-302503171.html

SOURCE IM Cannabis Corp.